The clinical entity now known as Wegener's granulomatosis was first reported in 1936. Since then the disease's histopathology has been clarified, although its etiology remains unknown. Treatment requires immunosuppressant therapy and careful following of affected patients. The present report reviews the historical background for the discovering of Wegener's granulomatosis and current clinical considerations.
The discovery of Wegener's granulomatosis
It was in 1936, at the 29th Congress of the German Pathological Society in Breslau, that I first reported on a previously unknown, unusual, and distinct disease entity. My report had a quite straightforward title, "Generalized, septic vascular diseases," and was based on three of my own autopsy cases. Histologically, the disease was characterized by granulomatous, necrotizing, and ulcerous inflammatory processes in the respiratory tract and a number of internal organs, as well as by necrotizing granulomatous vasculitis and focal glomerulonephritis. These three fundamental pathological changes were later to be termed the characteristic "triad" of features [23] .
Young, innocent, and full of enthusiasm, I spoke of a "'new disease." My opinion was supported by some of the best-known German pathologists present at the congress, including Aschoff (Freiburg), Fahr (Hamburg), and Schiirmann (Berlin) [52] .
In 1939, I published a detailed report based on the same three cases, referring to them as a "singular rhinogenie granulomatosis" [53] . Even today, this article is still considered to present the classical description of the "new" disease.
Yet, how did this discovery come about? It required certain preconditions, combined with favorable circumstances and pure coincidences. In 1932, the Head of the Institute of Pathology at the University of Kiel, Professor Leonhard Jores (who was also a privy councillor), agreed to employ me. I was the youngest member of the institute staff, and he appointed me under the following conditions: "First, you will work for 4 years in the autopsy room in order to acquire a thorough knowledge of pathology; however, during this time you will write no scientific articles!" I duly fulfilled these requirements and, working diligently every day, gained a sound basic knowledge of morphological pathology from Councillor Jores himself (the author of "The anatomical basis of important diseases" [35] ), his prosector Professor Dr. Arthur Schulz, and the senior consultant Dr. Kurt Wolff. My three excellent teachers were all full-blooded morphologists. They taught me how to see and comprehend, and trained and improved my "visual memory," which is so important for a morphologist. At that time, the major fields of study pursued at the institute in Kiel were disorders of the blood vessels, kidneys, and spleen.
As Kiel is not only a port visited regularly by the fleets of many nations but also a harbor from which the German navy sets sail for foreign shores, we had the opportunity to become acquainted with a multitude of rare diseases. I was thus able to gain experience rapidly. As a lecturer's assistant and the person responsible for taking care of the extensive anatomical collection of the institute, I was able to intensify this knowledge. I was soon familiar with all the forms of tuberculosis and syphilis, abdominal typhus, and bacillary dysentery. The rarer diseases that I encountered included one case each of periarteritis nodosa, Bang's disease (brucellosis), and Boeck's disease (sarcoidosis). The autopsy room was an Eldorado for pathologists. Most diseases observed were in their "pure" forms, as their clinical courses were seldom influenced or altered by therapy. Of course, in those days there were no sulfonamides or antibiotics.
It was in Kiel, at the end of June 1934, that I performed my first postmortem examination on a case of granulomatosis in a 38-year-old truck driver. The initial presenting symptom in this patient had been pain in his jaw. He then suffered a common cold with nasal crusting; in the next 2 months he developed a saddle nose deformity with intolerable fetor. His subsequent clinical course included involvement of the paranasal sinuses accompanied by a hearing loss. Soon afterwards, he had attacks of septic fever together with signs of nephritis. Six months after the onset of the disease the patient died of uremia. The postmortem findings revealed the classical triad of features now known as Wegener's granulomatosis and thus confirmed the typical disease course.
When I presented my microscopic and macroscopic findings, Jores and Schulz simply said: "We have never seen anything of the kind; this case is quite exceptional. You must study the case very carefully!" In those days, scientists were generously allowed to study and evaluate their own unusual cases alone. There was no "teamwork" as such, but no one needed to fear plagiarism. One was allowed to work on one's own, left to one's own devices and with all the problems the work involved. However, colleagues were always prepared to offer their full support whenever microscopic investigations or other extensive and expensive studies had to be performed.
In 1934, Jores retired and Martin Staemmler of Chemnitz became his successor as full professor of pathology. Schulz and Wolff left Kiel. After Staemmler had restructured the institute together with two assistants that had followed him from Chemnitz to Kiel, he was offered the chair of pathology in Breslau, which he accepted in the spring of 1935. His two assistants stayed in Kiel, and Professor Hiickel of G6ttingen became head of the institute on a provisional basis. Httckel was an experienced histologist and when I showed him my case of granulomatosis, he said: "Wegener, that is something new; you must publish the case."
In the autumn of 1935, Staemmler asked me to join him in Breslau. By this time I was the last remaining member of the old Kiel group. After all of Henke's coworkers had left Breslau, Staemmler created a completely new and very young group. Staemmler and his senior consultant, Professor Feyrter, were both only 42 years old. The nine assistants, aged 25-28 years, included Eger and Merkel, who were later to become professors of pathology at G6ttingen and Kiel, respectively, as well as Wienbeck, who carried out research in bone marrow diseases but fell during the Second World War.
In Breslau, the gateway to both the East and the West, we encountered an overwhelming amount of autopsy material of varying nature. By the summer of 1936 1 had experience with over 4000 autopsies, 1200 of which I had performed and evaluated myself. It was here, in the spring of 1936, that I carried out a postmortem examination on my second case of granulomatosis in a 36-year-old woman. The clinical course of her disease was similar to that of my first case. She initially had a common cold with inflammatory changes in the nasal mucosa accompanied by crusting and leading to putrid necrosis in her nose and septal perforation. The final phase of her disease was characterized by sepsis and F. Wegener: Wegener's granulomatosis involvement of her kidneys. The patient died 6.5 months after the onset of the disease. Autopsy again provided the typical findings: namely, the classical triad of features.
Staemmler provided me with the organs of my third case of granulomatosis -a 33-year-old woman, on whom a postmortem examination had been performed in Chemnitz at the beginning of 1934. This case was consistent with the two previous ones. The woman had initially suffered a common cold with nasal granulations and bloody, purulent secretions. The subsequent course of the disease was characterized by sepsis and involvement of the kidneys. The patient died 4 months after the onset of the disease. The autopsy results again revealed a rhinogenic granulomatosis and the classical triad of features.
Thus, I now had made three similar observations of a truly rare disease entity, which represented an unexpected accumulation of case material. Feyrter, probably the most outstanding pathologist of our time, shared a study room with me for 1 year and remarked: "Wegener, that is the ever-fascinating and mysterious law of clusters." Despite his vast experience gained in Vienna, even he had never before encountered such cases. He and Staemmler encouraged me to study the three cases carefully and to publish them. They stressed that my cases represented something special and apparently new.
In the autumn of 1936, our "young" institute was given the honor and, at the same time, the major task of organizing and hosting the Congress of the German Pathological Society. Everyone who possibly could had to "take the stage." Thus, I gave a 10-min presentation on the subject of the "new" disease. At that time I was aware of four similar cases: the three of my own and the first-ever published case of its type, i.e., that of Klinger [36] in 1931. He had described his case in his article on "borderline types" of periarteritis nodosa. Heinz Klinger was an old schoolfriend of mine; we had been in parallel classes at the Kaiser Wilhelm High School in Wilhelmshaven. We then studied and lived together in Munich from 1926 to 1929, and maintained a life-long friendship. Therefore, I was naturally aware of the work he had performed under R6ssle and Schiirmann to obtain his doctorate in Berlin. Had I known of the two other cases, namely those published in 1932 by Hoffmann [32] in Hamburg and by R6ssle [48] in Berlin in 1933, I would have been even more certain that I really had discovered a new disease. This disease was on the verge of being discovered; somebody had to do it, and I just happened to be the one.
The first three researchers to describe this disease all emphasized the special nature of their observations. However, each of them had only observed one single case. They were therefore not in a position to recognize that a new disease had been "born." Being obliged to speak at the congress in 1936 made me courageous and led me to express myself clearly. The opinions of my tutors and other experienced pathologists lent strong support to my belief that my three cases really were something special and new.
Strangely, and probably in accordance with Feyrter's "law of clusters," three further cases of granulomatosis were observed in Germany. In 1941, Postel and Laas [43] reported their postmortem findings in two cases, and Staehelin [49] made a further pertinent observation.
The Norwegian Ringertz, in 1947 [46] , and the Swede Johnsson, in 1948 [34] , were the first to use the term "Wegener's granulomatosis" in describing their cases. In 1954, the Americans Godman and Churg [23] presented a literature review of 22 cases and added 7 of their own.
Since that time, the term "Wegener's granulomatosis" has been accepted worldwide. All attempts at freeing the name of the disease from the proper name, Wegener, have failed [1, 21, 54] .
I should like to conclude this section by summarizing what is necessary for a pathologist to discover a new disease: good teachers, vast experience in the autopsy room, a sharp eye, a few extraordinary cases, being at the right place at the right time, a good deal of enthusiasm and, above all, luck in encountering a series of cases.
Pathological findings
Although Wegener's granulomatosis (WG) has now been known for over 50 years, many aspects of this disease still remain to be clarified. This is even true of a number of anatomical findings.
WG begins with granulomatous changes, as Fienberg [22] was able to establish after decades of research. The primary granulomas form and develop in connective tissue, but without vascular involvement. The vasculitis that accompanies the disease is a secondary feature that presents at a later stage. This fact is often not heeded, and WG is frequently mistaken for systemic vasculitis. However, in full-blown cases of WG, both disease processes are in competition with each other during the stage of generalization. At times they counterbalance each other, but sometimes either the granulomatous process or the vasculitis predominates. Both processes can change from organ to organ. The primary granulomas can remain unaltered for long periods of timesometimes up to a decade -at their site of origin [22] and are relatively quiescent until the active phase of the disease begins. In the phase of generalization widespread vessel-bound granulomas can be seen [54] : these are miliary nodules composed of histiocytes and epithelioid cells surrounded by a rim of mononuclear cells exhibiting a radiating arrangement and not infrequently containing giant cells (Fig. 1) . Central necrosis can often be observed; R6ssle [48] referred to "microabscesses" if large numbers of leukocytes were involved in this process. In some cases, the fully developed disease is dominated by widespread dissemination of such miliary granulomas affecting a number of organs, such as the lungs, the spleen, and the kidneys. However, at the primary site of disease -usually the respiratory tract -as well as in the other organs involved, extensive granulation tissue is most frequently seen together with areas of necrotic change (Figs. 5-7) . In addition to the scattered (Figs. 2, 3) . Moreover, varying amounts of histiocytes, monocytes, granulocytes, plasma cells, and lymphocytes are seen. Usually there are only a few eosinophilic leukocytes and cases of pronounced eosinophilia are rare [54, 58] .
There are wide variations in the numbers of giant cells found in the granulomas, ranging from abundant to sparse. These giant cells have a variety of different shapes and vary greatly in size; they are sometimes square and fragmented and are occasionally rich in cytoplasm. Some of the cells are small with grumous nuclei. It is not clear whether these cells are at an early stage of development or whether they are aging and declining. Inside palisades of histiocytes, polymorphic and often very large giant cells appear (Fig. 5) . The histiocytes themselves are also polymorphic, varying in size and shape, with polychromasia of the nuclei, amounts of cytoplasm ranging from scanty to abundant, and cells ranging from thin to overly thick (Figs. 2, 3, 5, 8 ). However, the factors responsible for this astonishing polymorphism remain to be defined.
The granulomas, often with wide areas of necrosis, may resemble large infarcts, particularly in the lungs, the spleen, and the kidneys. Sometimes it is possible to demonstrate involvement of the blood vessels. More often, however, this evidence is lacking; the granulomas then appear to spread in the region of an end-artery. On the other hand, in the above-mentioned organs, varying numbers of differently sized nodular lesions occur. In rare cases a whole organ is affected by a necrotic granuloma (Figs. 4, 5) .
Although superimposed suppuration can be caused by a mixture of bacterial and viral infections, the friable and rapidly necrotizing granulomas in the upper respiratory tract can remain aggressive and destroy adjacent tissue, particularly cartilage and bone (Fig. 6 ). This leads to septal perforations, with frequent saddle nose deformities and invasion of the sinuses, skull base and orbit. It is not clear how these extensive granulomatous vegetations behave when confronted with the successful modes of treatment employed nowadays, or how they regress and eventually heal. To date, no such tissue studies have been performed. However, this is quite understandable, as very extensive postmortem examinations would be necessary.
The necrosis that occurs both inside and in conjunction with the granulomas is almost exclusively a coagulation necrosis or caseation. In the lungs, however, colliquative necrosis also occurs (Fig. 7) . During this process, completely new cavities or caverns can develop, which seem to collapse if bronchial drainage is performed. A fact that continues to puzzle pathologists is that often no or only a few pulmonary hemorrhages occur in these cases, even when numerous large granulomas and necrotic areas occur, since surely these vascular areas are destroyed like in cases of capillaritis accompanied by severe bleeding [51, 57] .
If therapy is successful, the pulmonary nodules are soon no longer visible on X-ray pictures. Again, the reasons are unclear. Is it possible that no coarse scars re- The clinical course of WG, for example on the surface of the mucous membranes (in the larynx, trachea, intestines, ureter, glandular ducts, etc.), is generally as follows: granuloma formation, occasionally with stenosis; necrosis; ulceration, occasionally hemorrhage; perforation; and then scarring, with stenosis in some cases. In the small intestine this leads to a disease course similar to that seen in abdominal typhus.
From the morphological point of view, the second major feature of WG, vasculitis, is even more polymorphic. Vasculitis also generally originates in granulomas of the respiratory tract, where its earliest and -as the disease progresses -its most advanced stages can be observed. There are a multitude of quite different presentations, which cannot simply be dismissed as various degrees of a necrotizing vasculitis, although this mistake is often made. In many cases, the clinical and anatomical picture is dominated by a necrotizing vasculitis similar to the microscopic form of polyarteritis nodosa, which corresponds to the hypersensitivity angiitis described by Zeek [59] . There are also cases of classical polyarteritis nodosa (as reported by Kussmaul-Maier [38] ) with the involvement of medium-sized arteries and the formation of multiple aneurysms [54] . However, severe necrotizing forms are also encountered that cannot be classified among the normal vasculitides (Fig. 11) . Moreover, vascular processes are seen in WG that have the appearance of allergic angiitis or angiitic granulomatosis (Figs. 8,  11 ), of rheumatoid and rheumatic vascular diseases, of (Fig. 10) , and of granulomatous arteritis (Fig. 11) . The pathologist is faced with a remarkable multiplicity of different vascular lesions, affecting the whole vascular system and extending from the veins via the capillaries, arterioles and arteries to the aorta and the endocardium of the atrial walls [55] . It remains to be clarified whether the types of endangitis obliterans observed in WG (Figs. 12, 13 ) represent a further vascular disease process or simply healing processes. The morphologist is captivated by the variety of different forms of vasculitis that can occur in this disease. The reasons for this polymorphism have not yet been defined, however. There is still no well-ordered survey of this kaleidoscope of vasculitic processes, for which there is also no common name. It is only possible to summarize the situation by stating that there is a strangely variable form of vasculitis that is peculiar to WG.
The third feature of the classical triad, involvement of the kidneys, is also characterized by a variety of clinical and anatomical pictures. On the one hand, as in other organs, there are scattered, sometimes necrotizing granulomas of various sizes in addition to varyingly disseminated vasculitic processes of all kinds together with their sequelae: thromboses, hemorrhages, and infarcts. Moreover, there is often considerable interstitial inflammatory infiltration, above all in areas with destruction of tubules. On the other hand, specific pathological changes also occur within the kidney itself. These alterations consist of necrotic and thrombotic changes in individual loops or in larger sections of the renal glomeruli, whereby only a few, several or nearly all of the renal corpuscles may be affected. Moreover, there are capsular vegetations, crescent formations, and fibrin deposits in the glomeruli with involvement of varying amounts of granulocytes. Destruction of Bowman's capsule or of the whole glomerulus can occur as a result of granulomatous vegetations [53, 54] .
A striking feature is periglomerulitis, which is often severe and sometimes of a leukocytic or granulomatous nature. All of the alterations range from minimal in-
If one breathes life into the motionless pictures that have been presented thus far in order to describe WG, the true, infinitely polymorphic face of the disease reveals itself. It is then possible to comprehend the succession and coexistence of the various pathological changes: their genesis, formation, development, growth, flourishing, aging, and decline. This is true not only of the granuloma but also of the vasculitis, as well as inflammatory and necrotizing processes. All of the stages of such a process can take place at the same time and at the same place in a single organ or in numerous organs, anywhere or everywhere in the body. In some cases, the disease progresses constantly. Sometimes, however, there are also quiescent periods, spontaneous or therapyinduced remissions or even cases of cure. All reactions can be slow and sluggish or sudden and unexpected; the course can even be fulminant. The disease can "smoulder" for a relatively long time -months or years [22] before "catching fire." These conceptions, which are all based solely on morphological evidence, help us to understand this multiplicity of most different, often extraordinary, and widely ranging clinical courses. The pathological picture of WG, as described here, must present a disease that plays a key role in similar or even related diseases of immunological etiology that border upon each other or even overlap to some extent.
Concluding remarks
Thirty years after the discovery of WG as an independent, new disease entity [52, 53] , I published a detailed monograph [54] in which I gave an exhaustive description of the pathological anatomy and the various clinical courses of the disease. The article was based on three further autopsy cases of my own, as well as on the pertinent literature available at that time. In addition to the classical rhinogenic granulomatosis, the form of the disease that begins in the lower respiratory tract -trachea, bronchi and lungs -was now also known. This type of WG was loosely termed by a number of French authors "le Wegener d6capit6," and about the same time was described in the United States as a "limited" form [8] . Until this milder form was reported, only the uniformly fatal type of WG had been known in Europe. In some of these latter cases only high-dose corticosteroid treatment had resulted in remissions or an increased life expectancy.
The use of cytotoxic chemotherapy to treat patients with WG dates back to the 1954 report of Fahey et al. [16] . Since then, a number of medical centers have reported favorable responses to various immunosuppressive agents. Typical of the painstaking studies initiated are the ongoing investigations at the National Institutes of Health in Bethesda, Maryland (Fauci et al. [17] [18] [19] [20] ) and at the Mayo Clinic in Rochester, Minnesota (DeRemee et al. [9] [10] [11] [12] [13] [14] 42] ). The work of both these groups has resulted in exciting, new findings con- There is no doubt that Fauci should be credited for his work in proving that cyclosphosphamide can be used successfully to treat WG. He has also developed a treatment protocol involving the administration of cyclophosphamide in combination with prednisone that is currently used worldwide to manage and control WG (particularly in severe cases). In spite of its possible fatal side effects, cyclophosphamide remains the drug of first choice for treating WG. The milder forms of WG observed clinically can involve only one or a few organs (but not the kidneys) and have been associated with occasional spontaneous remissions. However° they have also understandably led to experiments using less drastic therapeutic agents. In certain cases, although for poorly understood reasons, trimethoprim-sulfamethoxazole seems to be quite effective [9, 13, 33] .
The ELK classification was recommended by DeRemee [10, 14] (E stands for the head and neck area, L for the lungs, and K for the kidneys). This system has proved helpful not only for the classification and clinical evaluation of disease in individual cases but also for establishing when to begin therapy. This classification is in principle used today in the Federal Republic of Germany (e.g., in Kiel and Zweibrticken [28] ), although mostly in an extended or modified form.
Important ongoing work on the clinical aspects, diagnosis, and therapy of WG has been performed in the clinics and research centers at the German universities of [24] [25] [26] [27] [28] [29] [30] [31] ) and Heidelberg (Andrassy et al. [2] [3] [4] [5] ). Most publications have been in English, but readers in German-speaking countries will be interested to know that some articles have been published in their language [2, 4, 5, 10, 14, [24] [25] [26] [28] [29] [30] [31] .
The list of references appended to this article represents only a limited selection but should suffice as a guide for further reading. With the constantly increasing numbers of publications on WG and the vasculitides peculiar to the disease, it is difficult to survey the literature available on the subjects in question. However, there have been a striking number of single case reports [25] . Indeed, out of a total of 59 articles published in 1988 that mentioned WG in their titles, 25 were reports on single cases.
Revolutionary progress in the diagnosis, therapy, and prognosis of WG has been achieved since the discovery of anti-cytoplasmatic antibodies directed against plasma granules of neutrophilic polymorphonuclear leukocytes and monocytes (ACPA/ANCA) [7, 15, 27, 39-45, 47, 56] . The ACPA is constantly positive in the active phase of WG. However, ACPA titers in serum are elevated when the disease worsens but become lower as the patient's condition improves. If the patient achieves complete remission or is cured, the test is negative, but becomes positive again if there is a recurrence [2] [3] [4] [5] . With the help of this very sensitive test appropriate treatment of the various stages of WG is possible [24, 25, 28, 30, 31, 50] .
In only a small proportion of cases is a positive ACPA seen in the so-called initial phase, i.e., in early forms of the disease. The reason for this finding is connected with the etiology of WG still being unknown. We still do not know at which point and as a result of which factors the changes occur that cause the immunological reactions that are typical of the disease. Thus, some of the complaints attributed to the initial phase of WG when case histories are recorded can most likely be assumed to have been caused by non-specific inflammatory processes or forerunners of the disease itself.
As the disease begins and progresses in the head and neck region, the ENT specialist has an important role to play in cases of WG. He is, so to speak, in the front line, as the majority of patients with this disease will consult an ENT specialist first. He therefore sees all stages of the disease, particularly the early forms. His investigations can lead to at least a tentative diagnosis of WG and will give him cause to refer the patient to a suitable clinic so that the diagnosis can be confirmed, treatment initiated, further observations carried out, and the necessary care provided.
The fundamental otorhinolaryngological findings in cases of WG, as well as the various disease courses, have been reported by Kornblut et al. [37] and McDonald et al. [42] from the American research centers at Bethesda and the Mayo Clinic, respectively. An article in German by Beigel [6] deals with the clinical findings, the diagnosis, and the differential diagnosis. Reports based on the FLK classification [10, 12, 14, 28] show at a glance to what extent the head and neck region is affected by WG.
Much has changed in the diagnosis and treatment of WG during the past 50 years. What was once a uniformly fatal disease is now very manageable by knowledgeable clinicians. It is only through the efforts of such personsaided by the diligence of the morphologist -that lives can be saved and patients returned safely to their families and professions.
